Analysis of approaches to the preparation of social reporting of pharmaceutical enterprises




social responsibility, corporate social responsibility, pharmaceutical industry, pharmaceutical enterprise, social reporting, social practices


Aim. The work aims are to find and justify unified approaches to social reporting for pharmaceutical enterprises, which would enable the evaluation and comparison of the social activities of organizations across different market segments by all stakeholders.

Materials and methods. Materials are scientific and scientific-methodical publications, regulatory and legislative documents on social responsibility, and information from the official websites of domestic manufacturing pharmaceutical enterprises, which were included in the top 20 marketing organizations by the volume of drugs’ pharmacy sales in 2022, to social reporting. Methods: critical analysis, content analysis, generalization, and interpretation of results.

Results. The study found that while social reporting of pharmaceutical enterprises is an established practice abroad, there is no unified approach to their preparation, resulting in a diverse range of content.

In Ukraine, it was observed that only JSC “Pharmak”, Arterium Corporation, and PJSC RPC “Borshchagivskyi chemical and pharmaceutical plant” publish reports on their corporate social responsibility. Other pharmaceutical companies provide information on their social measures either in management reports or in news. The phenomenon of social reporting of domestic pharmaceutical enterprises and the approaches to its preparation are still in the early stages of development. Therefore, this study proposes a framework for the content of such reports that caters to various stakeholders.

Conclusions. Domestic manufacturing pharmaceutical enterprises apply different criteria and different approaches to inform society about their social activities, making it difficult to compare their contribution to the sustainable development of the country.

It has been established that domestic pharmaceutical manufacturing enterprises need to strengthen their efforts in this direction. The preparation of transparent social reports based on international standards is one of the tools for promoting openness, improving the company’s activities, and ensuring accountability in the context of social responsibility.

Author Biographies

N. O. Tkachenko, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

PhD, DSc, Professor, Head of the Department of Management and Pharmacy Economics

I. Ya. Horodetska, Danylo Halytsky Lviv National Medical University, Ukraine

PhD, Associate Professor of the Department of Organization and Economics of Pharmacy

O. R. Levytska, Danylo Halytsky Lviv National Medical University, Ukraine

PhD, DSc, Associate Professor, Department of Organization and Economics of Pharmacy


Breharia, S. (2016). Etapy stanovlennia korporatyvno-sotsialnoi vidpovidalnosti ukrainskoho biznesu [Stages of formation of social corporate responsibility ukrainian business]. Naukovi zapysky Instytutu politychnykh i etnonatsionalnykh doslidzhen im. I.F. Kurasa NAN Ukrainy, (5-6), 312-326. [in Ukrainian].

International standard ISO 26000. Guidance on social responsibility (ISO 26000:2010(E)).

Budstandart Online. (2019). Nastanovy shchodo sotsialnoi vidpovidalnosti: Natsionalnyi standart Ukrainy DSTU ISO 26000:2019 (ISO 26000:2010, IDT) [Guidelines on social responsibility: National Standard of Ukraine ISO 26000:2019, IDT].. [in Ukrainian].

Bila, S. O. (2017, June 2). Yevropeiskyi dosvid uspishnoi praktyky sotsialnoi vidpovidalnosti biznesu: oriientyry dlia Ukrainy [European experience of successful practice of social responsibility of business: guidelines for Ukraine]. Yevropeyski studii v Ukraini: zdobutky, vyklyky ta perspektyvy. Collection of materials of the International Scientific and Practical Conference (pp. 35-40). Kyiv: Ukrainska Asotsiatsiia Vykladachiv i Doslidnykiv Yevropeiskoi Intehratsii [in Ukrainian].

Kholyavka, V., Huzar, U., & Leshko, Kh. (2021). Istorychni aspekty stanovlennia i rozvytku korporatyvnoi sotsialnoi vidpovidalnosti v Ukraini ta sviti [Historical aspects of formation and development of corporate social responsibility in Ukraine and the world]. Ekonomika ta upravlinnia pidpryiemstvamy, 56, 90-96. [in Ukrainian].

Mejia Reatiga, C. A., Gonzalez Barranco, S. E., & Torres-Saumeth, K. M. (2021). Corporate Social Responsibility in the pharmaceutical industry. Estudios De Administracion, 28(1), 32-60.

Oger, C. (2009). Corporate social responsibility in the pharmaceutical industry : between trend and necessity (Thesis). Toronto Metropolitan University.

Min, M., Desmoulins-Lebeault, F., & Esposito, M. (2017). Should pharmaceutical companies engage in corporate social responsibility? Journal of Management Development, 36(1), 58-70.

Commission of the European Communities. (2001). Green paper: promoting a European framework for corporate social responsibility (COM(2001) 366 final). Brussels: E. Commission.

Kirsanov, D. (2022, October 31). Aptechnyi prodazh za pidsumkamy 9 mis 2022 r. [Pharmacy sales according to the results of the 9th month of 2022]. Apteka, (37/38).

JSC Farmak.

PrJSC "Pharmaceutical Firm "Darnitsa".


JSC "Kyiv Vitamin Plant".

Cusum Pharm, LTD.

Pharmaceutical Company ''Zdorovia'', LTD.

Yuriya-Pharm, LTD.

InterChem, SLC.

PJSC SIC "Borshchahivskiy CPP".

Paskhaver, O. J., Verkhodova, L. T., & Aheieva, K. M. (2007). Svitovyi dosvid dlia Ukrainy: vzaiemovidnosyny velykoho kapitalu z vladoiu i suspilstvom [World experience for Ukraine: the relationship of big capital with the government and society]. Tsentr ekonomichnoho rozvytku. [in Ukrainian].

Del Castillo, M., Penagos, J., Navarro-Beltran, J., Polo, B., & Berrío, Y. (2011). [Methodological Strategies for Design and Implementation of the Programs of Corporate Social Responsibility in a Pharmaceutical Company Sector]. Ingeniare, (11), 45-52.

Haro-de-Rosario, A., Saraite, L., Gálvez-Rodríguez, M. & Caba-Pérez, M. (2016). La industria farmacéutica ante la demanda de responsabilidad social corporativa [The pharmaceutical industry in light of the demand for corporate social responsibility]. Perspectiva Empresarial, 3(1), 55-75.

Demir, M., & Min, M. (2019). Consistencies and discrepancies in corporate social responsibility reporting in the pharmaceutical industry. Sustainability Accounting, Management and Policy Journal, 10(2), 333-364.

Bratishko, Yu. S. (2021). Teoretychni ta praktychni pidkhody do upravlinnia systemoiu sotsialnoi vidpovidalnosti u farmatsii [Theoretical and practical approaches to managing the system of social responsibility in pharmacy (Doctoral Dissertation)]. National Pharmaceutical University, Kharkіv, Ukraine.

Smith, A. D. (2008). Corporate social responsibility practices in the pharmaceutical industry. Business Strategy Series, 9(6), 306-315.

Vitezic, N. (2010). A Measurement System of Corporate Social Responsibility in the Pharmaceutical Industry of the Region. International Journal of Management & Information Systems (IJMIS), 14(5), 57-68.

Droppert, H., Bennett, S. (2015). Corporate social responsibility in global health: An exploratory study of multinational pharmaceutical firms. Global Health, 11(1), 15.

Janga, A. (2018). Сorporate social responsibility in the pharmaceutical industry – a review of pharmaceutical companies in the United States and India. International Journal of Pharmacy and Biological Sciences, 8(1), 363-368.

Dănescu, T., & Popa, M. A. (2020). Public health and corporate social responsibility: exploratory study on pharmaceutical companies in an emerging market. Globalization and health, 16(1), 117.

Bae, G., Ahn, J. H., Lim, K. M., & Bae, S. (2022). Corporate social responsibility of pharmaceutical industry in Korea. Frontiers in pharmacology, 13, 950669.

Lee, H., Kim, S. Y., Kim, G., & Kang, H. Y. (2019). Public preferences for corporate social responsibility activities in the pharmaceutical industry: Empirical evidence from Korea. PloS one, 14(8), e0221321.

Qian, Y. (2016). Corporate Social Responsibility Practices of Pharmaceutical Companies in China: A Scale Development & Empirical Study. PhD thesis. Retrieved from

Yang, M., Wang, J., Maresova, P., & Akbar, M. (2022). Can the spending of corporate social responsibility be offset? Evidence from pharmaceutical industry. Economic Research-Ekonomska Istrazivanja, 35(1), 6279-6303.

Tsutsui, H. (2018). Factors Associated with Corporate Social Responsibility Reporting in Japanese Pharmaceutical Companies. WWU Honors Program Senior Projects.

Silva Filho, C. F., Benedicto, S. C. D., Sugahara, C. R., & Georges, M. R. R. (2019). Corporate Social Responsibility of Pharmaceutical Industry in Brazil. International Journal of Humanities and Social Science, 9(1).

Senthil Vadivu, S., & Raja, S. S. (2015). Corporate Social Responsibility of Pharmaceutical Companies in India. International Research Journal of Business and Management, 8(2), 15-19.

Nair, S. (2016). Corporate social responsibility of pharmaceutical companies in India. International Journal of Applied Research, 2(10), 163-166.

Vijayabanu, C., Vijayanand, V., Sai Prashanthi, S., Rajesh Kumar, R., Subaash, R., & Madhussodhanan. (2018). Corporate social responsibility (CSR) - A study with special reference to Indian pharma industry. Research Journal of Pharmacy and Technology, 11(4), 1663-1666.

Tkachenko, N. O. (2013). Analiz modelei sotsialnoi vidpovidalnosti farmatsevtychnoho biznesu [The analysis of social responsibility models in pharmaceutical business]. Farmatsevtychnyi Zhurnal, (1), 9-14. [in Ukrainian].

Tkachenko, N. O. (2018). Sotsialna vidpovidalnist u profesiinii diialnosti farmatsevtychnykh pratsivnykiv [Social responsibility in the professional activity of pharmaceutical workers]. Zaporizhzhia : ZDMU. [in Ukrainian].

Tkachenko, N. O. (2018). Vprovadzhennia kontseptsii sotsialnoi vidpovidalnosti v diialnist farmatsevtychnykh orhanizatsii [Introduction of the concept of social responsibility in the activity of pharmaceutical organizations]. Current issues in pharmacy and medicine: science and practice, 11(2), 238-244. [in Ukrainian].

Tkachenko, N. O., Hromovyk, B. P., & Knysh, E. H. (2015, May 22). Sotsialna vidpovidalnist fakhivtsiv farmatsii yak bazovyi element sotsialno vidpovidalnoi povedinky farmatsevtychnykh orhanizatsii [Social responsibility of pharmacy specialists as a basic element of socially responsible behavior of pharmaceutical organizations]. Upravlinnya yakistyu v farmatsiyi. Collection of materials of the 9th scientific and practical conference (рр. 127-128). Kharkiv: NFaU. [in Ukrainian].

Tkachenko, N. O., & Hromovyk, B. P. (2017). Kontseptualnyi analiz sotsialnoi vidpovidalnosti osobystosti ta yii intehruvannia u farmatsevtychnu praktyku [Conceptual analysis of social responsibility of the person and its integration in pharmaceutical practice]. Current issues in pharmacy and medicine: science and practice, 10(3), 342-347. [in Ukrainian].

Tkachenko, N. O., & Hromovyk, B. P. (2018). Modeliuvannia pravovoho polia formuvannia sotsialno vidpovidalnoi povedinky farmatsevtychnykh fakhivtsiv [Modeling the legal field of formation of socially responsible conduct among pharmacy specialists]. Current issues in pharmacy and medicine: science and practice, 11(1), 104-111. [in Ukrainian].

Posylkina, O. V., & Bratishko, Yu. S. (2016). Analiz suchasnykh tendentsii v upravlinni sotsialnoiu vidpovidalnistiu farmatsevtychnykh pidpryiemstv [The analysis of current trends in management of social responsibility of pharmaceutical enterprises]. Sotsialna farmatsiia v okhoroni zdorovia, 2(3), 5-17. [in Ukrainian].

Posylkina, O. V., & Bratishko, Yu. S. (2018). Analiz rehuliatornoi bazy upravlinnia sotsialnoiu vidpovidalnistiu farmatsevtychnykh pidpryiemstv [Regulatory base analysis of managing the pharmaceutical companies social responsibility]. Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, (1), 28-34. [in Ukrainian].

Tkachenko, N. O. (2020). Doslidzhennia stanu ta napriamiv sotsialnoi aktyvnosti subyektiv farmatsevtychnoho pidpryiemnytstva [The study of the state and directions of the social activity of pharmaceutical entrepreneurship]. Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, (3), 47-56. [in Ukrainian].

Profesiina asotsiatsiia korporatyvnoho upravlinnia. (2020). ESG transparency index 2020 Ukraine. [in Ukrainian].

Yevtushenko, O. V. (2013). Otsinka korporatyvnoi sotsialnoi vidpovidalnosti: metody, obiekty, pokaznyky [Assessment of corporate social responsibility: methods, objects, indicators]. Visnyk natsionalnoho tekhnichnoho universytetu "KhPI", 46, 53-63. [in Ukrainian].

Kharchuk, V. Yu. (2020). Analizuvannia mizhnarodnykh standartiv iz harmoniinoho rozvytku [Analysis of international standarts for sustainable development]. Ekonomika ta pidpryiemnytstvo, (6), 111-117. [in Ukrainian].

Global Reporting Initiative. (n.d.). Resource center. Standards.

AccountAbility. (n.d.). Standards.

SA8000:2014 Standard.

ISO 1400. Standards.

The Stakeholder Alliance (n.d.). The Sunshine Standards.

Bratishko, Yu. S., & Posylkina, O. V., & Novgorodska, L. M. (2016). Metodyka otsinky rivnia sotsialnoii vidpovidalnosti farmatsevtychnykh pidpryiemstv: metodychni rekomendatsii [Methodology for assessing the level of social responsibility of pharmaceutical enterprises: Guidelines]. Kyiv. [in Ukrainian].



How to Cite

Tkachenko NO, Horodetska IY, Levytska OR. Analysis of approaches to the preparation of social reporting of pharmaceutical enterprises. Current issues in pharmacy and medicine: science and practice [Internet]. 2023Jul.3 [cited 2024May24];16(2):186-93. Available from:



Original research